Pipeline — registered trials by phase
International Registry of Healthcare Workers Exposed to COVID-19 Patients (UNITY Global)
— · SARS-CoV Infection, Covid19 · Completed · est. 2021-08-05
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Certara is lead sponsor; 1 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-08-07Current report (material event)
- 10-Q2026-08-04Quarterly report
- 8-K2026-08-04Current report (material event)
- 8-K2026-08-04Current report (material event)
- SCHEDULE 13G/A2026-07-14SCHEDULE 13G/A
- SCHEDULE 13G/A2026-07-08SCHEDULE 13G/A
- 8-K2026-06-17Current report (material event)
- 8-K2026-05-15Current report (material event)
- 10-Q2026-05-11Quarterly report
- 8-K2026-05-11Current report (material event)
- D2026-04-28D
- 8-K2026-04-22Current report (material event)
- SCHEDULE 13G/A2026-04-06SCHEDULE 13G/A
- SCHEDULE 13G/A2026-04-06SCHEDULE 13G/A
- ARS2026-04-03Annual report to holders
- DEFA14A2026-04-03DEFA14A
- DEF 14A2026-04-03Proxy statement
- 8-K2026-03-31Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- 10-K2026-02-26Annual report
- 8-K2026-02-26Current report (material event)
- 8-K2025-12-11Current report (material event)
- SCHEDULE 13G/A2025-11-25SCHEDULE 13G/A
- SCHEDULE 13G2025-11-13SCHEDULE 13G
- 10-Q2025-11-06Quarterly report
- 8-K2025-11-06Current report (material event)
- 8-K2025-10-16Current report (material event)
- SCHEDULE 13G2025-10-09SCHEDULE 13G
- SCHEDULE 13G/A2025-10-07SCHEDULE 13G/A
- SCHEDULE 13G/A2025-08-13SCHEDULE 13G/A
- 10-Q2025-08-06Quarterly report
- 8-K2025-08-06Current report (material event)
- 8-K2025-05-22Current report (material event)
- 10-Q2025-05-05Quarterly report
- 8-K2025-05-05Current report (material event)
- SCHEDULE 13D/A2025-04-14SCHEDULE 13D/A
- 8-K2025-04-14Current report (material event)
- ARS2025-04-08Annual report to holders
- DEFA14A2025-04-08DEFA14A
- DEF 14A2025-04-08Proxy statement
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.